Maastricht University
The Netherlands
History
The Experimental Medicine ECNP Network was founded in 2013 as part of an initiative to build a European-wide consortium of academic centres dedicated to advancing human experimental medicine models in psychiatry. Recognising the crucial role of these models in bridging preclinical and clinical studies, the network was designed to foster collaboration between academia, industry, and SMEs.
Our global Network is actively working on developing trans-diagnostic biomarkers that will support the discovery and development of novel treatments in psychiatry. Examples of successful network-initiated activities include the development of a quantitative biological approach to understanding and classifying neuropsychiatric diseases (e.g., PRISM), and the validation of novel (e.g., task-based) measurements of anhedonia. More recently, the Network has been developing work packages aimed at improving the prediction of treatment response with fast-acting antidepressants. With these initiatives, we aim to accelerate and maximize the benefits of novel treatments for those most in need of them.
Members
Name | Organisation | City | Country |
Celso Arango | Hospital General Universitario Gregorio Marañon | Madrid | Spain |
Derek Buhl | Abbvie | Cambridge, Massachusetts | USA |
Philippe Danjou | Biotrial | Rennes | France |
Gerard Dawson | P1vital | Wallingford, Oxfordshire | United Kingdom |
Caroline Golden | Novartis | Basel | Switzerland |
Oliver Grimm | Johann Wolfgang Goethe University | Frankfurt am Main | Germany |
Catherine Harmer | University of Oxford | Oxford | United Kingdom |
Dennis Hernaus | Maastricht University | Maastricht | The Netherlands |
Martien Kas | University of Groningen | Groningen | The Netherlands |
Gitte M. Knudsen | Rigshospitalet | Copenhagen | Denmark |
Mitul Mehta | IoPPN - King's College London | London | United Kingdom |
Carmen Moreno | Hospital General Universitario Gregorio Marañon | Madrid | Spain |
Brian Murphy | Cumulus Neuroscience | Belfast | United Kingdom |
David Nutt | Imperial College London | London | United Kingdom |
Georgios Papazisis | Aristotle University of Thessaloniki | Thessaloniki | Greece |
Brenda Penninx | VU University Amsterdam | Amsterdam | The Netherlands |
Andreas Reif | University Hospital Frankfurt | Frankfurt | Germany |
Alessandro Serretti | University of Bologna | Bologna | Italy |
Paul Stokes | IoPPN - King's College London | London | United Kingdom |
Elizabeth Tunbridge | Boehringer Ingelheim International GmbH | Biberach an der Riß | Germany |
Daniel Umbricht | Gilgamesh Pharmaceuticals | NY | USA |
Nic van der Wee | Leiden University Medical Center | Leiden | The Netherlands |